2019 Conference Organizing Committee
Linda Pfiffner, President, ISRCAP
Steve Lee, Secretary/Treasurer, ISRCAP
Andrea Chronis-Tuscano, President Elect, ISRCAP
Joan Luby, Past President, ISRCAP
Beth Moroney, Administrator, ISRCAP
2019 Scientific Meeting Information
Nineteenth Biennial ISRCAP Scientific Meeting
"Treatment of Child and Adolescent Psychopathology: Controversies, Evidence, Novel Directions"
Wednesday, June 26 - Saturday, June 29, 2019
UCLA Luskin Conference Center, Los Angeles, California, USA
Who Could Attend
Mental health professionals interested in child and adolescent psychopathology and treatment of childhood mental health disorders should attend. Recent basic and applied research and current treatment strategies will be described and evaluated. Attendance is for ISRCAP members and persons sponsored by an ISRCAP member.
MARK DADDS, Ph.D.
Mark Dadds is a Principal Research Fellow of the National Health and Medical Research Council of Australia, and Professor of Psychology at the University of Sydney Australia. He is Director of the Child Behaviour Research Clinic which develops state-of-the-art treatments for children and adolescents with behavioural and emotional problems, and has developed and directed several national intervention programs for children, youth, and their families, at risk for mental health problems. He has been National President of the Australian Association for Cognitive and Behavioural Therapy, Director of Research for the Abused Child Trust of Queensland, Professor of Parenting Research at the Institute of Psychiatry, Kings College London and a recipient of several awards including an Early Career Award from the Division of Scientific Affairs of the Australian Psychological Society, the Ian Matthew Campbell Award for Excellence in Clinical Psychology, and Distinguished Career Award of the Australian Association of Cognitive and Behavioural Therapy. He has authored 4 books and over 240 papers on child and family psychology, and has given invited keynote addresses to international audiences throughout the world. He also practices as a clinical child psychologist and his treatment methods were the subject of the 2014 ABC TV documentary "Kids on Speed?" for which he was awarded the Inaugural APS Award for Media Engagement with Science.
BONNIE T. ZIMA, M.D., M.P.H.
Bonnie T. Zima, MD, MPH is Professor-in-Residence in the UCLA Department of Psychiatry and Behavioral Sciences, and Associate Director of the UCLA Center for Health Services and Society. Dr. Zima’s research is dedicated to improving the quality of child mental health care, with priority placed on children enrolled in Medicaid-funded outpatient programs and underserved, at risk child populations. Her research spans national pediatric hospitalization resource utilization and costs, validity of national quality measures, pediatric integrated care models, pediatric workforce development, and use of telehealth and mobile health technologies.
She is Principal Investigator (PI) of MH2™, Mobile Health for Mental Health, a web-based application to optimize stimulant medication treatment for children with ADHD, a five-year study to develop and pilot test integrated care models for children in two federally qualified health care centers in Chicago, and two-year study examining statewide capacity to track seven policy-relevant outcomes related to Medicaid-funded mental health care. Dr. Zima is also Co-Investigator on a three-year PCORI-funded randomized trial of a telehealth intervention to provide mental health services to children served within a network of federally qualified health care centers, 5-year SAMHSA-funded intervention to improve pediatric work force training related to child complex trauma, and lead child psychiatrist on the California Performance Outcomes Measures Study. Her research has received all three national research awards from the American Academy of Child and Adolescent Psychiatry (AACAP).
In addition, Dr. Zima was a member of the Institute of Medicine's Committee to Evaluate the Supplemental Security Income Disability Program for Children with Mental Disorders, and is a standing member of the Behavioral Health and Substance Abuse Steering Committee for the National Quality Forum (NQF), AACAP Committee on Research and the American Psychiatric Association (APA) Council on Quality Care. She is Consulting Editor for the Journal of the American Academy of Child & Adolescent Psychiatry, Deputy Editor for the Journal of Child and Adolescent Psychopharmacology, and Distinguished Fellow of AACAP and APA.